fbpx
QQQ
+ 4.58
299.52
+ 1.51%
DIA
+ 5.52
304.13
+ 1.78%
SPY
+ 6.84
369.88
+ 1.82%
TLT
+ 0.27
138.37
+ 0.19%
GLD
+ 0.05
159.02
+ 0.03%

Why Is It Moving? Looking Into Why AcelRx Pharmaceuticals's Stock is Trading Higher Today

January 19, 2021 10:48 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Why Is It Moving? Looking Into Why AcelRx Pharmaceuticals's Stock is Trading Higher Today

The Price And Volume Action In AcelRx Pharmaceuticals's Stock Today

AcelRx Pharmaceuticals's (NASDAQ:ACRX) stock is trading up 17.3% to a price of $2.31. The stock's volume is currently 4.79 million, which is roughly 110.29% of its recent 30-day volume average of 4.34 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: AcelRx Pharmaceuticals shares are trading higher after the company announced an investor-initiated study of DSUVIA in a cardiac surgery enhanced recovery program. The company was also awarded a patent for 'Storage and dispensing devices for administration of oral transmucosal dosage forms'.

Insights On Recent Price Action

The moving average price of the stock over the past 50 days was $1.46 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $2.29 and as low as $0.7.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.

Posted-In:

Movers Trading Ideas

Related Articles

68 Biggest Movers From Yesterday

Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 414.3% to close at $8.28 on Wednesday after the company announced a merger agreement with ReShape Lifesciences. read more

12 Health Care Stocks Moving In Wednesday's Intraday Session

  read more

45 Stocks Moving In Wednesday's Mid-Day Session

Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 175% to $4.4250 after the company announced a merger agreement with ReShape Lifesciences. read more

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  read more